Galera Therapeutics, Inc. Separation Agreements
3 Contracts & Agreements
- Separation Agreement and General Release, dated August 31, 2024, between the Company and Chris Degnan (Filed With SEC on December 13, 2024)
- Separation Agreement and General Release by Robert A. Beardsley, dated June 4, 2024 (Filed With SEC on August 14, 2024)
- Separation Agreement and General Release by Mark Bachleda, dated August 16, 2023 (Filed With SEC on November 14, 2023)